556283984	556283984	CD	B-NP	O
|	|	NNP	I-NP	O
KHMC	KHMC	NNP	I-NP	O
|	|	VBD	B-VP	O
34746228	34746228	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
315103	315103	CD	B-NP	O
|	|	CC	I-NP	O
5/22/2001	5/22/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
BILATERAL	BILATERAL	NNP	I-NP	I-protein
PLEURAL	PLEURAL	NNP	I-NP	I-protein
EFFUSION	EFFUSION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/23/2001	9/23/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/22/2001	10/22/2001	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
RECURRENT	RECURRENT	NN	B-NP	O
PLEURAL	PLEURAL	NN	I-NP	O
EFFUSIONS	EFFUSIONS	NNS	I-NP	O
AND	AND	CC	O	O
SHORTNESS	SHORTNESS	NNP	B-NP	O
OF	OF	IN	B-PP	O
BREATH	BREATH	NNP	B-NP	O
FROM	FROM	NNP	I-NP	O
YELLOW	YELLOW	NNP	I-NP	O
NAIL	NAIL	NNP	I-NP	O
SYNDROME	SYNDROME	NNP	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CHRONIC	CHRONIC	NNP	B-NP	O
OBSTRUCTIVE	OBSTRUCTIVE	NNP	I-NP	O
PULMONARY	PULMONARY	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ANXIETY	ANXIETY	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

DIABETES	DIABETES	NNS	B-NP	O
MELLITUS	MELLITUS	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

CHRONIC	CHRONIC	NNP	B-NP	O
RENAL	RENAL	NNP	I-NP	O
INSUFFICIENCY	INSUFFICIENCY	NNP	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
DYSPNEA	DYSPNEA	NN	B-NP	O
ON	ON	NN	I-NP	O
EXERTION	EXERTION	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Cabaniss	Cabaniss	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
70-year-old	70-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
yellow	yellow	JJ	B-NP	O
nail	nail	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
diabetes	diabete	NNS	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
multiple	multiple	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
since	since	IN	B-PP	O
October	October	NNP	B-NP	O
2001	2001	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
first	first	JJ	I-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
from	from	IN	B-PP	O
5/25/01	5/25/01	CD	B-NP	O
-	-	HYPH	I-NP	O
11/20/01	11/20/01	CD	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
pericardial	pericardial	JJ	I-NP	O
window	window	NN	I-NP	O
and	and	CC	O	O
600	600	CD	B-NP	O
cc	cc	NN	I-NP	O
were	be	VBD	B-VP	O
drained	drain	VBN	I-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
pericardium	pericardium	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
pleural	pleural	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
drained	drain	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
cor	cor	NN	B-NP	O
pulmonale	pulmonale	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
second	second	JJ	I-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
from	from	IN	B-PP	O
8/28/01	8/28/01	CD	B-NP	O
-	-	HYPH	I-NP	O
8/10/01	8/10/01	CD	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Aen	Aen	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
during	during	IN	B-PP	O
that	that	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
again	again	RB	B-ADVP	O
her	her	PRP$	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
were	be	VBD	B-VP	O
tapped	tap	VBN	I-VP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
mild	mild	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
moderate-large	moderate-large	JJ	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
with	with	IN	B-PP	O
fibrinous	fibrinous	JJ	B-NP	O
strands	strand	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
RV	RV	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
45/11	45/11	CD	B-NP	O
,	,	,	O	O
PA	PA	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
38/18	38/18	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
22	22	CD	B-NP	O
,	,	,	O	O
LV	LV	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
127/14	127/14	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
constrictive	constrictive	JJ	I-NP	O
pericardial	pericardial	JJ	I-NP	O
disease	disease	NN	I-NP	O
or	or	CC	O	O
restrictive	restrictive	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
malignant	malignant	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
exudated	exudate	VBN	I-VP	O
.	.	.	O	O

ANCA	ANCA	NN	B-NP	B-protein
,	,	,	O	O
ANA	ANA	NN	B-NP	O
,	,	,	O	O
SPEP	SPEP	NN	B-NP	B-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
mass	mass	NN	B-NP	O
or	or	CC	I-NP	O
hydronephrosis	hydronephrosis	NN	I-NP	O
,	,	,	O	O
24	24	CD	B-NP	O
hour	hour	NN	I-NP	O
urine	urine	NN	I-NP	O
collection	collection	NN	I-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
protein	protein	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
third	third	JJ	I-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
Beysa	Beysa	NNP	B-NP	O
Dward	Dward	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
from	from	IN	B-PP	O
11/15/01	11/15/01	CD	B-NP	O
-	-	HYPH	I-NP	O
1/16/01	1/16/01	CD	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
increasing	increase	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
,	,	,	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
iron	iron	NN	B-NP	O
deficient	deficient	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
thoracentesis	thoracentesis	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
exudative	exudative	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

PFTs	PFT	NNS	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
FEV1	FEV1	NN	I-NP	O
of	of	IN	B-PP	O
.9	.9	CD	B-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
FVC	FVC	NN	I-NP	O
of	of	IN	B-PP	O
1.26	1.26	CD	B-NP	O
,	,	,	O	O
43	43	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
FEV1/FVC	FEV1/FVC	NN	I-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
TLC	TLC	NN	I-NP	O
of	of	IN	B-PP	O
2.07	2.07	CD	B-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	O	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
DLCO	DLCO	NN	I-NP	O
of	of	IN	B-PP	O
8.42	8.42	CD	B-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
TB	TB	NN	B-NP	B-protein
with	with	IN	B-PP	O
serial	serial	JJ	B-NP	B-protein
ASBs	ASB	NNS	I-NP	I-protein
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
yellow	yellow	JJ	B-NP	O
nail	nail	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
lymphedema	lymphedema	NN	B-NP	O
and	and	CC	O	O
yellow	yellow	JJ	B-NP	O
fingernails	fingernail	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
high	high	JJ	B-NP	O
dose	dose	NN	I-NP	O
Vitamin	Vitamin	NN	I-NP	O
E	E	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
evaluated	evaluate	VBN	B-VP	O
by	by	IN	B-PP	O
CT	CT	NN	B-NP	O
surgery	surgery	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
pleurodesis	pleurodesis	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
aggressively	aggressively	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
diuretics	diuretic	NNS	I-NP	O
were	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
September	September	NNP	B-NP	O
2001	2001	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
10	10	CD	I-NP	O
pound	pound	NN	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
baseline	baseline	NN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
worsened	worsen	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
was	be	VBD	B-VP	O
208	208	CD	B-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
she	she	PRP	B-NP	O
currently	currently	RB	B-ADVP	O
weighs	weigh	VBZ	B-VP	O
238	238	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
231	231	CD	B-NP	O
pounds	pound	NNS	I-NP	O
a	a	DT	B-NP	O
month	month	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
wheezing	wheeze	VBG	I-VP	O
,	,	,	O	O
but	but	CC	O	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
cough	cough	NN	I-NP	O
with	with	IN	B-PP	O
white	white	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
some	some	DT	B-NP	O
substernal	substernal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
sharp	sharp	JJ	B-ADJP	O
with	with	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
lasts	last	VBZ	B-VP	O
for	for	IN	B-PP	O
awhile	awhile	NN	B-NP	O
without	without	IN	B-PP	O
radiation	radiation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
increasing	increase	VBG	I-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
afebrile	afebrile	JJ	B-NP	O
,	,	,	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
103	103	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
24	24	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
95/41	95/41	CD	I-NP	O
and	and	CC	O	O
satting	satte	VBG	B-VP	O
91	91	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Albuterol	Albuterol	NN	B-NP	O
and	and	CC	O	O
Atrovent	Atrovent	JJ	B-NP	O
nebs	neb	NNS	I-NP	O
without	without	IN	B-PP	O
improvement	improvement	NN	B-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NN	I-NP	O
160	160	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
600	600	CD	I-NP	O
cc	cc	NN	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lymphedema	Lymphedema	NNP	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-ADJP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Right	Right	RB	B-NP	O
tibial	tibial	JJ	I-NP	O
plateau	plateau	NN	I-NP	O
fracture	fracture	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2000	2000	CD	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
open	open	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
and	and	CC	I-NP	O
internal	internal	JJ	I-NP	O
fixation	fixation	NN	I-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
reconstruction	reconstruction	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Anxiety	Anxiety	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Yellow	Yellow	JJ	B-NP	O
nail	nail	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
interstitial	interstitial	JJ	I-NP	O
nephritis	nephritis	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Peptic	Peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Left	Left	JJ	B-NP	O
oophorectomy	oophorectomy	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Denies	Denies	NNP	B-NP	O
headache	headache	NN	I-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
URI	URI	NN	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
wheezing	wheezing	NN	B-NP	O
,	,	,	O	O
reflux	reflux	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
or	or	CC	I-NP	O
hematuria	hematuria	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
constipation	constipation	NN	I-NP	O
and	and	CC	O	O
dark	dark	JJ	B-NP	O
stools	stool	NNS	I-NP	O
from	from	IN	B-PP	O
iron	iron	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
lower	low	JJR	B-ADJP	O
back	back	RB	B-ADVP	O
and	and	CC	O	O
shoulder	should	JJR	B-NP	O
pain	pain	NN	I-NP	O
from	from	IN	B-PP	O
gout	gout	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Colchicine	Colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
q.o.d.	q.o.d.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Zestril	Zestril	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
d.	d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

K-Dur	K-Dur	NN	B-NP	O
20	20	CD	B-NP	O
milliequivalents	milliequivalent	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
4	4	CD	B-NP	O
.	.	.	O	O

Procrit	Procrit	NN	B-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
b.i.w.	b.i.w.	RB	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Glyburide	Glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Iron	Iron	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
160	160	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Atrovent	Atrovent	NN	B-NP	O
inhalers	inhaler	NNS	I-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	RB	B-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Magnesium	Magnesium	NNP	B-NP	O
gluconate	gluconate	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Zantac	Zantac	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
13	13	CD	I-NP	I-protein
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	O
E	E	NN	I-NP	O
1200	1200	CD	B-NP	O
units	unit	NNS	I-NP	O
q.	q.	NN	I-NP	O
d.	d.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Allopurinol	Allopurinol	DT	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Xanax	Xanax	NN	B-NP	O
.125	.125	CD	I-NP	O
-2.5	-2.5	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Percocet	Percocet	IN	B-PP	O
1-2	1-2	CD	B-NP	O
tabs	tab	NNS	I-NP	O
q.4-6h	q.4-6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Albuterol	Albuterol	NN	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Levofloxacin	Levofloxacin	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
caused	cause	VBN	I-VP	O
acute	acute	JJ	B-NP	O
interstitial	interstitial	JJ	I-NP	O
nephritis	nephritis	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	NNP	B-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Lives	Live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
,	,	,	O	O
ETOH	ETOH	NN	B-NP	B-protein
socially	socially	RB	B-ADVP	O
,	,	,	O	O
just	just	RB	B-ADVP	O
occasionally	occasionally	RB	I-ADVP	O
,	,	,	O	O
Tobacco	Tobacco	NNP	B-NP	O
,	,	,	O	O
quit	quit	VBD	B-VP	O
10	10	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
-	-	HYPH	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
30	30	CD	I-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
IV	IV	CD	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
mother	mother	NN	I-NP	O
died	die	VBD	B-VP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
88	88	CD	I-NP	O
.	.	.	O	O

Father	Father	NNP	B-NP	O
died	die	VBD	B-VP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
87	87	CD	I-NP	O
of	of	IN	B-PP	O
natural	natural	JJ	B-NP	O
causes	cause	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
98.4	98.4	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
112	112	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
132/84	132/84	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
,	,	,	O	O
older	old	JJR	B-NP	O
woman	woman	NN	I-NP	O
in	in	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	JJ	B-NP	O
,	,	,	I-NP	O
extraocular	extraocular	JJ	I-NP	O
movements	movement	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
OP	OP	NNP	B-NP	O
clear	clear	JJ	I-NP	O
,	,	,	I-NP	O
mouth	mouth	JJ	I-NP	O
moist	moist	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
carotids	carotid	NNS	I-NP	O
without	without	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Tachycardic	Tachycardic	JJ	B-NP	O
,	,	,	I-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Pulses	Pulse	NNS	B-NP	O
:	:	:	O	O
Intact	Intact	NNP	B-NP	O
Chest	Chest	NNP	I-NP	O
:	:	:	O	O
Decreased	Decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-NP	O
half	half	JJ	I-NP	O
way	way	NN	I-NP	O
up	up	RP	B-PRT	O
lung	lung	NN	B-NP	O
fields	field	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
E-A	E-A	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
crackles	crackle	NNS	B-NP	O
on	on	IN	B-PP	O
top	top	NN	B-NP	O
of	of	IN	B-PP	O
effusions	effusion	NNS	B-NP	O
,	,	,	O	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apices	apex	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Obese	Obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
non-tender	non-tender	JJ	I-NP	O
,	,	,	I-NP	O
non-distended	non-distended	JJ	I-NP	O
,	,	,	I-NP	O
active	active	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NN	B-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hips	hip	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
or	or	CC	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
.	.	.	O	O

Nails	Nail	NNS	B-NP	O
:	:	:	O	O
Thickened	Thicken	VBN	B-VP	O
,	,	,	O	O
yellow	yellow	JJ	B-NP	O
fingers	finger	NNS	I-NP	O
and	and	CC	I-NP	O
toenails	toenail	NNS	I-NP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-ADJP	O
:	:	:	O	O
Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
II-XII	II-XII	NNP	B-NP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
,	,	,	O	O
sensation	sensation	NN	B-NP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	B-NP	O
,	,	,	I-NP	O
motor	motor	JJ	I-NP	O
strength	strength	NN	I-NP	O
5/5	5/5	CD	I-NP	O
upper	upper	JJ	I-NP	O
extremities	extremity	NNS	I-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
,	,	,	O	O
DTS	DTS	NNS	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
toes	toe	NNS	B-NP	O
were	be	VBD	B-VP	O
equivocal	equivocal	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-ADJP	O
:	:	:	O	O
Hemoccult	Hemoccult	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
per	per	IN	B-PP	O
emergency	emergency	NN	B-NP	O
department	department	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
126	126	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.2	3.2	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
85	85	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
31	31	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
31	31	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.7	1.7	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	B-protein
96	96	CD	I-NP	I-protein
,	,	,	O	O
ALT	ALT	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
,	,	,	O	O
AST	AST	NNP	B-NP	O
13	13	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
82	82	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.2	0.2	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
3.4	3.4	CD	I-NP	I-protein
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.7	9.7	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
protein	protein	NN	I-NP	O
7.2	7.2	CD	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	O
0.00	0.00	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
11.3	11.3	NN	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
36.1	36.1	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
361	361	CD	B-NP	I-protein
,	,	,	O	O
MCV	MCV	NN	B-NP	B-cell_line
89.4	89.4	CD	I-NP	I-cell_line
.	.	.	O	O

Differential	Differential	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
is	be	VBZ	B-VP	O
12	12	CD	B-NP	O
,	,	,	O	O
82	82	CD	B-NP	O
neutrophils	neutrophil	NNS	I-NP	B-cell_type
,	,	,	O	O
6	6	CD	B-NP	O
monocytes	monocyte	NNS	I-NP	B-cell_type
.	.	.	O	O

ESR	ESR	NN	B-NP	B-protein
99	99	CD	I-NP	I-protein
.	.	.	O	O

PT	PT	NN	B-NP	B-protein
12.2	12.2	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
24.4	24.4	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.0	1.0	CD	I-NP	I-protein
.	.	.	O	O

D-Dimer	D-Dimer	NN	B-NP	O
>	>	SYM	B-VP	O
1000	1000	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
Normal	Normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
rate	rate	NN	B-NP	O
114	114	CD	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
voltage	voltage	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
,	,	,	O	O
Q-wave	Q-wave	NN	B-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
,	,	,	O	O
Q-wave	Q-wave	NNP	B-NP	O
flattening	flatten	VBG	B-VP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
and	and	CC	O	O
F	F	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST	ST	NN	I-NP	O
or	or	CC	I-NP	O
T-wave	T-wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NN	I-NP	O
:	:	:	O	O
Bilateral	Bilateral	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
right	right	NN	B-NP	O
=	=	SYM	B-VP	O
left	left	JJ	B-NP	O
,	,	,	I-NP	O
left	left	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
is	be	VBZ	B-VP	O
bigger	big	JJR	B-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
2001	2001	CD	I-NP	O
.	.	.	O	O

LENIS	LENIS	NN	B-NP	B-protein
:	:	:	O	O
Negative	Negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
limited	limited	JJ	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

SUMMARY	SUMMARY	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
70-year-old	70-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
home	home	NN	B-NP	O
02	02	NN	I-NP	O
requirement	requirement	NN	I-NP	O
and	and	CC	O	O
yellow	yellow	JJ	B-NP	O
nail	nail	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
failure	failure	NN	I-NP	O
of	of	IN	B-PP	O
home	home	NN	B-NP	O
diuretics	diuretic	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
needed	need	VBN	B-VP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
effusions	effusion	NNS	I-NP	O
tapped	tap	VBN	B-VP	O
along	along	IN	B-ADVP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
definitive	definitive	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
yellow	yellow	JJ	I-NP	O
nail	nail	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
initially	initially	RB	B-ADVP	O
diuresed	diurese	VBD	B-VP	O
Ms.	Ms.	NNP	B-NP	O
Jowell	Jowell	NNP	I-NP	O
with	with	IN	B-PP	O
IV	IV	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
Diuril	Diuril	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
brisk	brisk	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
overnight	overnight	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
short	short	JJ	B-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
did	do	VBD	B-VP	O
a	a	DT	B-NP	O
thoracentesis	thoracentesis	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
side	side	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
1.5	1.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
clear	clear	JJ	B-NP	O
,	,	,	I-NP	O
yellowish	yellowish	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
fluid	fluid	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
cytology	cytology	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
chemistries	chemistry	NNS	B-NP	O
and	and	CC	O	O
returned	return	VBD	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
exudative	exudative	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
with	with	IN	B-PP	O
predominant	predominant	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
cytology	cytology	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
malignant	malignant	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
team	team	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
,	,	,	O	O
who	who	WP	B-NP	O
decided	decide	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
pleurodesis	pleurodesis	NN	I-NP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
effusions	effusion	NNS	B-NP	O
from	from	IN	B-PP	O
recurring	recur	VBG	B-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
consulted	consult	VBD	B-VP	O
thoracic	thoracic	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
requested	request	VBD	B-VP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
thoracentesis	thoracentesis	NN	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
her	her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
for	for	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
malignancy	malignancy	NN	B-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
9/19/01	9/19/01	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
atelectasis	atelectasis	NN	B-NP	O
and	and	CC	O	O
having	have	VBG	B-VP	O
to	to	TO	I-VP	O
do	do	VB	I-VP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
without	without	IN	B-PP	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
areas	area	NNS	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
and	and	CC	I-NP	O
left	left	JJ	I-NP	O
lungs	lung	NNS	I-NP	O
that	that	WDT	B-NP	O
appeared	appear	VBD	B-VP	O
nodular	nodular	JJ	B-ADJP	O
or	or	CC	O	O
opacified	opacifie	VBN	B-VP	O
and	and	CC	O	O
could	could	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
malignancies	malignancy	NNS	B-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
surgery	surgery	NN	I-NP	O
also	also	RB	B-ADVP	O
requested	request	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
clearance	clearance	NN	I-NP	O
before	before	IN	B-SBAR	O
any	any	DT	B-NP	O
definitive	definitive	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
new	new	JJ	B-NP	O
onset	onset	NN	I-NP	O
SVT	SVT	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
obtained	obtain	VBD	B-VP	O
a	a	DT	B-NP	O
stress	stress	NN	I-NP	O
MIBI	MIBI	NNP	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
9/4/01	9/4/01	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
for	for	IN	B-PP	O
surgery	surgery	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Women	Women	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
cardiothoracic	cardiothoracic	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O
took	take	VBD	B-VP	O
biopsies	biopsy	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pleura	pleura	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
reportedly	reportedly	RB	I-VP	O
thickened	thicken	VBN	I-VP	O
and	and	CC	O	O
yellow	yellow	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
took	take	VBD	B-VP	O
a	a	DT	B-NP	O
wedge	wedge	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
.	.	.	O	O

Those	Those	DT	B-NP	O
biopsies	biopsy	NNS	I-NP	O
have	have	VBP	B-VP	O
returned	return	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
revealed	reveal	VBD	B-VP	O
mild	mild	JJ	B-NP	O
nonspecific	nonspecific	JJ	I-NP	O
interstitial	interstitial	JJ	I-NP	O
pneumonitis	pneumonitis	NN	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
bronchiolitis	bronchiolitis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
diaphragm	diaphragm	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
biopsied	biopsie	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
lymphoid	lymphoid	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
fibrous	fibrous	JJ	I-NP	B-DNA
tissue	tissue	NN	I-NP	I-DNA
fragment	fragment	NN	I-NP	I-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
tube	tube	NN	I-NP	O
placed	place	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
operation	operation	NN	B-NP	O
and	and	CC	O	O
tolerated	tolerate	VBD	B-VP	O
that	that	IN	B-SBAR	O
well	well	RB	B-ADVP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
that	that	DT	B-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
unstable	unstable	JJ	B-ADJP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
PACU	PACU	NN	I-NP	O
team	team	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
MICU	MICU	NN	B-NP	B-protein
overnight	overnight	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
extubated	extubate	VBD	B-VP	O
without	without	IN	B-PP	O
problems	problem	NNS	B-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
overnight	overnight	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
saturations	saturation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
readmitted	readmitte	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
medicine	medicine	NN	I-NP	O
team	team	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
8/28/01	8/28/01	CD	B-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
that	that	IN	B-SBAR	O
procedure	procedure	NN	B-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
tube	tube	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
side	side	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
drain	drain	VB	I-VP	O
much	much	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
did	do	VBD	B-VP	O
a	a	DT	B-NP	O
thoracentesis	thoracentesis	NN	I-NP	O
on	on	IN	B-PP	O
8/28/01	8/28/01	CD	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
removed	remove	VBD	B-VP	O
1	1	CD	B-NP	O
liter	liter	NN	I-NP	O
of	of	IN	B-PP	O
turbid	turbid	NN	B-NP	O
,	,	,	O	O
yellowish	yellowish	JJ	B-NP	O
brown	brown	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
chemistries	chemistry	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
lymphocyte	lymphocyte	NN	I-NP	B-cell_type
and	and	CC	I-NP	O
macrophage	macrophage	NN	I-NP	O
predominance	predominance	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
cytology	cytology	NN	I-NP	O
is	be	VBZ	B-VP	O
still	still	RB	I-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
draining	drain	VBG	I-VP	O
much	much	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
thoracic	thoracic	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
team	team	NN	I-NP	O
decided	decide	VBD	B-VP	O
to	to	TO	I-VP	O
pleurodese	pleurodese	VB	I-VP	O
her	her	PRP	B-NP	O
with	with	IN	B-PP	O
doxycycline	doxycycline	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
effective	effective	JJ	B-ADJP	O
in	in	IN	B-PP	O
yellow	yellow	JJ	B-NP	O
nail	nail	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
in	in	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pleurodesis	pleurodesis	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
3/29/01	3/29/01	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
this	this	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
little	little	JJ	B-NP	O
chest	chest	NN	I-NP	O
tube	tube	NN	I-NP	O
drainage	drainage	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
48	48	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
chest	chest	NN	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
pulled	pull	VBN	I-VP	O
on	on	IN	B-PP	O
6/2/01	6/2/01	CD	B-NP	O
.	.	.	O	O

Mrs.	Mrs.	NNP	B-NP	O
Musson	Musson	NNP	I-NP	O
's	's	POS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
was	be	VBD	B-VP	O
much	much	RB	I-VP	O
improved	improve	VBN	I-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
thoracentesis	thoracentesis	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid-90	mid-90	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Colasante	Colasante	NNP	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ostermann	Ostermann	NNP	I-NP	O
will	will	MD	B-VP	O
determine	determine	VB	I-VP	O
if	if	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
fluid	fluid	NN	B-NP	O
reaccumulating	reaccumulate	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
pleurodesis	pleurodesis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
can	can	MD	B-VP	O
then	then	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
pleurodesis	pleurodesis	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
an	an	DT	B-NP	O
initial	initial	JJ	I-NP	O
pleurodesis	pleurodesis	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
.	.	.	O	O

Mrs.	Mrs.	NNP	B-NP	O
Blan	Blan	NNP	I-NP	O
was	be	VBD	B-VP	O
tachycardic	tachycardic	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
tachycardic	tachycardic	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
and	and	CC	I-NP	O
Diuril	Diuril	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
probably	probably	RB	B-ADVP	O
over	over	IN	B-PP	O
diuresed	diurese	VBN	B-VP	O
,	,	,	O	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
2-3	2-3	CD	B-NP	O
liters	liter	NNS	I-NP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
hours	hour	NNS	B-NP	O
overnight	overnight	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
tachycardic	tachycardic	JJ	B-ADJP	O
with	with	IN	B-PP	O
rates	rate	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
140s-150s	140s-150	NNS	I-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
converted	convert	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
calcium	calcium	NN	I-NP	O
channel	channel	NN	I-NP	O
blockers	blocker	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
Diltiazem	Diltiazem	NNP	I-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Diltiazem	Diltiazem	NN	B-NP	O
SR	SR	NN	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
multifocal	multifocal	JJ	B-NP	O
HL	HL	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
MICU	MICU	NN	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
did	do	VBD	B-VP	O
a	a	DT	B-NP	O
pulsus	pulsus	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
only	only	RB	B-NP	O
8	8	CD	I-NP	O
mmhg	mmhg	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
bedside	bedside	NN	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
a	a	DT	B-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
trace	trace	NN	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
MIBI	MIBI	NNP	B-NP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
clearance	clearance	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
cardiothoracic	cardiothoracic	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
107-129	107-129	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
from	from	IN	B-PP	O
115/70	115/70	CD	B-NP	O
-	-	HYPH	I-NP	O
110/70	110/70	CD	I-NP	O
at	at	IN	B-PP	O
peak	peak	JJ	B-NP	O
stress	stress	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
dobutamine	dobutamine	NN	B-NP	O
was	be	VBD	B-VP	O
non-ischemic	non-ischemic	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
response	response	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
EKG	EKG	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
dobutamine	dobutamine	NN	B-NP	O
was	be	VBD	B-VP	O
non-ischemic	non-ischemic	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
definite	definite	JJ	I-NP	O
regional	regional	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
defects	defect	NNS	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
stress	stress	NN	I-NP	O
or	or	CC	I-NP	O
rest	rest	NN	I-NP	O
images	image	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
only	only	RB	B-NP	O
planer	planer	NN	I-NP	O
images	image	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
difficulty	difficulty	NN	B-NP	O
with	with	IN	B-PP	O
positioning	positioning	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
hemodynamically	hemodynamically	RB	B-NP	O
secondary	secondary	JJ	I-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
technically	technically	RB	I-VP	O
limited	limit	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
Ms.	Ms.	NNP	B-NP	O
Duensing	Duensing	NNP	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
for	for	IN	B-PP	O
only	only	RB	B-NP	O
the	the	DT	I-NP	O
first	first	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
PO	PO	NN	B-NP	O
diuretics	diuretic	NNS	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-VP	O
decreased	decrease	VBD	I-VP	O
to	to	TO	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
,	,	,	O	O
along	along	IN	B-ADVP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
.	.	.	O	O

Ms.	Ms.	NNP	B-NP	O
Handy	Handy	NNP	I-NP	O
's	's	POS	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
is	be	VBZ	B-VP	O
1.7	1.7	CD	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
varied	vary	VBD	B-VP	O
between	between	IN	B-PP	O
1.6-1	1.6-1	CD	B-NP	O
.9	.9	CD	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
contraction	contraction	NN	I-NP	O
alkalosis	alkalosis	NN	I-NP	O
with	with	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
replete	replete	VB	I-VP	O
her	her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Svinth	Svinth	NNP	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
.	.	.	O	O

Ms.	Ms.	NNP	B-NP	O
Reppell	Reppell	NNP	I-NP	O
has	have	VBZ	B-VP	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
glyburide	glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
d.	d.	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
that	that	IN	B-SBAR	O
therapy	therapy	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
finger	finger	NN	I-NP	O
sticks	stick	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
control	control	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Rheumatology	Rheumatology	NN	B-NP	O
.	.	.	O	O

Ms.	Ms.	NNP	B-NP	O
Chad	Chad	NNP	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
gout	gout	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
concerned	concern	VBN	B-ADJP	O
about	about	IN	B-PP	O
precipitating	precipitate	VBG	B-VP	O
a	a	DT	B-NP	O
gout	gout	NN	I-NP	O
attack	attack	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
aggressive	aggressive	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
colchicine	colchicine	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
her	her	PRP$	B-NP	O
allopurinol	allopurinol	NN	I-NP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
d	d	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
Vitamin	Vitamin	NN	I-NP	O
E	E	NN	I-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
yellow	yellow	JJ	I-NP	O
nail	nail	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
iron	iron	NN	I-NP	O
and	and	CC	I-NP	O
Procrit	Procrit	NN	I-NP	O
treatment	treatment	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Souza	Souza	NNP	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
to	to	TO	B-VP	O
administer	administer	VB	I-VP	O
her	her	PRP	B-NP	O
twice	twice	RB	I-NP	O
weekly	weekly	JJ	I-NP	O
Procrit	Procrit	NN	I-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
to	to	TO	B-VP	O
aid	aid	VB	I-VP	O
her	her	PRP	B-NP	O
in	in	IN	B-PP	O
regain	regain	NN	B-NP	O
her	her	PRP$	B-NP	O
strength	strength	NN	I-NP	O
and	and	CC	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
joints	joint	NNS	I-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
gout	gout	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
make	make	VB	I-VP	O
follow-up	follow-up	JJ	B-NP	O
appointments	appointment	NNS	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Amicone	Amicone	NNP	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
sees	see	VBZ	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Burchell	Burchell	NNP	I-NP	O
She	She	NNP	I-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Donkin	Donkin	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Allopurinol	Allopurinol	DT	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
d.	d.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
d.	d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Colchicine	Colchicine	NN	B-NP	O
.6	.6	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.o.d.	q.o.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Diltiazem	Diltiazem	NN	B-NP	O
SR	SR	NN	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Procrit	Procrit	NN	B-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
S.C.	S.C.	NNP	B-NP	O
b.i.w.	b.i.w.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Iron	Iron	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Glyburide	Glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
d.	d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Atrovent	Atrovent	NNP	B-NP	O
inhaler	inhaler	IN	B-PP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	RB	B-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
d.	d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Magnesium	Magnesium	NNP	B-NP	O
gluconate	gluconate	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
d.	d.	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Percocet	Percocet	IN	B-PP	O
1-2	1-2	CD	B-NP	O
tabs	tab	NNS	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	RB	B-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Ranitidine	Ranitidine	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
two	two	CD	I-NP	O
tablets	tablet	NNS	I-NP	B-protein
PO	PO	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	O
E	E	NN	I-NP	O
1200	1200	CD	B-NP	O
units	unit	NNS	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
d.	d.	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Atrovent	Atrovent	NNP	B-NP	O
nebulizer	nebulizer	IN	B-PP	O
.5	.5	CD	B-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

K-Dur	K-Dur	NN	B-NP	O
10	10	CD	B-NP	O
milliequivalents	milliequivalent	NNS	I-NP	O
PO	PO	NNP	B-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DWAYNE	DWAYNE	NNP	B-NP	O
ZETINO	ZETINO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AW04	AW04	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TOD	TOD	NN	B-NP	O
METTS	METTS	NNS	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
QJ99	QJ99	NNP	I-NP	O
OT111/074684	OT111/074684	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
36918	36918	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

NEBQXU6506	NEBQXU6506	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
4/16/01	4/16/01	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/26/01	1/26/01	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
REX	REX	NNP	B-NP	B-protein
BALLARD	BALLARD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
QJ99	QJ99	NNP	I-NP	O
MEL	MEL	NNP	I-NP	O
MCCULLOCK	MCCULLOCK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SX532	SX532	NNP	I-NP	O

